Is Meloxicam Good for Shoulder Pain Relief?

Meloxicam is an effective option for many types of shoulder pain, particularly when inflammation is driving the problem. A trial focused specifically on acute soft-tissue shoulder conditions found that patients treated with meloxicam experienced pain relief within the first one to three days. But the picture is more nuanced than “take this pill and feel better,” because the type of shoulder problem you have, how long you plan to take the drug, and whether you are also healing from an injury or surgery all shape whether meloxicam is the right choice.

What Meloxicam Actually Does in an Inflamed Shoulder

Meloxicam belongs to the class of nonsteroidal anti-inflammatory drugs, or NSAIDs, and it works by dialing down the chemical signals that cause swelling and pain in injured or irritated tissues. What sets it apart from older NSAIDs like ibuprofen or naproxen is that it preferentially targets the COX-2 enzyme, which is more directly involved in inflammation, while being somewhat gentler on the COX-1 enzyme that helps protect your stomach lining. This selectivity does not make it risk-free, but it does tilt the side-effect balance in a direction many people find easier to tolerate.

Shoulder pain often involves inflamed tendons, bursae, or joint capsules. When rotator cuff tendons swell, or when the bursa between the tendon and bone becomes irritated in impingement syndrome, that inflammatory cascade is exactly what meloxicam targets. The drug does not repair damaged tissue or reverse arthritis, but it can knock back the pain and swelling enough for you to move more freely, sleep better, and participate in rehabilitation exercises that address the underlying problem.

Direct Evidence From Shoulder-Specific Trials

Unlike many NSAIDs that get prescribed for shoulder pain based on general musculoskeletal evidence, meloxicam has actually been studied in shoulder conditions directly. A randomized trial in patients with acute soft-tissue rheumatism of the shoulder, which includes conditions like bursitis, tendinitis, and periarthritis, compared once-daily meloxicam at 7.5 mg and 15 mg against piroxicam. Meloxicam performed comparably to piroxicam across the board, and a significantly higher proportion of meloxicam-treated patients reported pain relief within day one or day three of treatment.¹ There was no meaningful difference between the two meloxicam doses in terms of effectiveness, which is worth knowing because it suggests the lower dose may be enough for many people. Fewer patients in the meloxicam groups withdrew from the study due to side effects.

That rapid onset of relief, often within the first day, matters practically. Shoulder pain can be debilitating, disrupting sleep and making simple tasks like reaching for a seatbelt or combing your hair miserable. A drug that starts working quickly gives you a window to begin gentle movement before stiffness sets in and compounds the problem.

How It Stacks Up Against Corticosteroid Injections

One of the most common alternatives to oral NSAIDs for shoulder pain is a corticosteroid injection directly into the affected area. A systematic review and meta-analysis that pooled data from multiple trials compared NSAIDs head-to-head with corticosteroid injections for shoulder pain. The findings were mixed in an interesting way. For achieving full remission of symptoms at four to six weeks, NSAIDs were less effective than corticosteroid injections. But for the outcomes that arguably matter more day to day, pain relief and improvement in the range of active shoulder abduction, there was no significant difference between the two approaches.²

What this means in practice is that if your goal is to reduce pain and get your shoulder moving better, an oral NSAID like meloxicam can get you a similar result to a cortisone shot without the needle, the clinic visit, or the small but real risks that come with joint injections. If your goal is complete resolution of the episode within a month or so, a corticosteroid injection has a better track record. Many clinicians start with an oral NSAID and move to injection if the response is insufficient, which is a reasonable approach given that the pill is less invasive.

What Clinical Guidelines Recommend

Professional guidelines for rotator cuff disorders, which encompass the most common causes of shoulder pain, support using NSAIDs as part of early treatment. A 2022 clinical practice guideline for diagnosing and managing rotator cuff disorders stated that NSAIDs and acetaminophen may be useful to reduce pain in the short term.³ A separate systematic review of multiple clinical practice guidelines found a similar consensus: NSAID prescriptions and corticosteroid injections were both presented as modalities that may be recommended to decrease pain.⁴

The language in these guidelines is deliberately careful. “May be useful” and “may be recommended” reflect the reality that NSAIDs are a symptom-management tool, not a cure. The guidelines consistently pair medication recommendations with physical therapy and rehabilitation, treating the drugs as a bridge that makes rehab tolerable rather than a standalone fix.

The Stomach Advantage Over Older NSAIDs

One of the strongest arguments for choosing meloxicam over other NSAIDs is its digestive side-effect profile. A meta-analysis of randomized controlled trials found that patients using meloxicam had roughly a third fewer gastrointestinal adverse events compared with non-COX-2-selective NSAIDs. Rates of dyspepsia were lower, serious upper GI complications like ulcers and bleeding were about half as common, and fewer patients had to stop taking the drug because of stomach problems.⁵ In a head-to-head trial against naproxen for rheumatoid arthritis, meloxicam matched naproxen’s effectiveness while producing fewer GI adverse events: about 30% of meloxicam patients reported GI issues versus roughly 45% on naproxen, and two naproxen patients developed ulcers while none in the meloxicam group did.⁶

There is an important caveat here. A UK study of over 19,000 meloxicam users in general practice found that doctors were already channeling higher-risk patients toward meloxicam precisely because of its perceived GI safety. Patients receiving meloxicam were at least twice as likely as patients on other NSAIDs to have a recent history of digestive problems or treatment for them.⁷ This means real-world GI event rates for meloxicam users may look higher than in trials, not because the drug is more dangerous, but because the people taking it already had riskier stomachs. A separate cohort study confirmed that in the absence of existing GI risk factors, the incidence of digestive problems with meloxicam was low.⁸

Heart and Kidney Risks to Know About

All NSAIDs carry some cardiovascular and kidney risk, and meloxicam is no exception. A broad evidence review noted that oral NSAIDs for musculoskeletal pain can increase the risk of heart attack, heart failure, high blood pressure, and kidney problems.⁹ A systematic review looking specifically at meloxicam’s cardiovascular profile found a small overall increase in composite cardiovascular risk, driven mainly by vascular events. The review did not find a significant increase in heart attack risk on its own, and kidney risk was not elevated.¹⁰

For most people treating a few weeks of shoulder pain, these risks are quite low. They become more relevant if you have pre-existing heart disease, high blood pressure, kidney issues, or if you end up taking meloxicam for months. The general guidance with any NSAID is to use the lowest effective dose for the shortest time needed, and that principle applies to meloxicam for shoulder pain. If your shoulder problem is clearly an acute inflammatory episode, a two- to three-week course is usually sufficient. Chronic, ongoing use is where the risk profile starts to shift.

The Healing Trade-Off After Tendon Injury or Repair

Here is where the relationship between meloxicam and shoulder pain gets genuinely complicated. The same anti-inflammatory properties that relieve pain may also interfere with the body’s natural healing process in tendons. A scoping review examining NSAIDs and soft-tissue healing found that the majority of studies, including animal models, lab studies, and limited human data, showed that COX-2-selective inhibitors (the class meloxicam belongs to) had a negative impact on soft-tissue healing. The lab studies specifically pointed to harm in the biological processes involved in tendon regeneration, including the proliferation of tendon cells and the synthesis of collagen.¹¹

An animal study looking at this question in surgically repaired rotator cuff tendons added an important nuance about timing. Rats given NSAIDs during the later stages of healing, when the tendon was in its proliferative repair phase, had significantly weaker repairs compared with those given the drug earlier or not at all.¹² The implication is that when you take the drug relative to the healing timeline may matter as much as whether you take it. Early, short-term use for acute pain control might be less problematic than prolonged use that overlaps with the critical repair window.

This creates a real tension for anyone with a torn or partially torn rotator cuff. The pain makes daily life and rehabilitation difficult, and meloxicam can relieve that pain effectively. But the same drug may slow the tendon’s recovery. Most orthopedic surgeons and sports medicine physicians handle this by limiting NSAID use to the first week or two after an acute injury or surgery, then tapering off as the tendon enters its more active healing phases. If you are dealing with a tendon tear rather than straightforward bursitis or impingement, this is a conversation worth having explicitly with your doctor.

Meloxicam as Part of a Rehabilitation Plan

Meloxicam works best for shoulder pain when it is treated as one piece of a broader rehabilitation strategy, not a standalone solution. A clinical trial studying shoulder impingement syndrome prescribed all participants a daily 15 mg dose of meloxicam for three weeks alongside a structured exercise program. The exercise regimen began with stretching of the posterior capsule and trapezius muscles along with range-of-motion exercises like pendulum movements and wall walking. As pain decreased, patients progressed to strengthening exercises for the rotator cuff and shoulder girdle muscles.¹³

This combination reflects how experienced clinicians actually use NSAIDs for shoulder conditions. The drug reduces inflammation and pain enough that you can participate meaningfully in physical therapy, which is where the real long-term benefit comes from. Meloxicam’s once-daily dosing is a practical advantage here. Instead of timing doses around therapy sessions the way you might with a shorter-acting NSAID, you take it once in the morning and get relatively steady coverage throughout the day.

After Shoulder Surgery

Post-surgical pain management is shifting away from opioid-heavy regimens, and NSAIDs including meloxicam are playing a growing role in that shift. A prospective randomized trial comparing a multimodal nonopioid pain protocol against a standard opioid-based regimen after arthroscopic shoulder labral surgery found that the nonopioid approach provided equivalent pain control, a similar adverse reaction profile, and equivalent patient satisfaction.¹⁴ These multimodal protocols typically combine an NSAID with acetaminophen, ice, nerve blocks, and sometimes other non-opioid medications.

The practical significance is substantial. Opioids after shoulder surgery come with drowsiness, constipation, nausea, and the risk of dependence. If you can get equivalent pain relief from an NSAID-centered protocol, you recover more comfortably and participate in early rehab more actively. The tension with tendon healing discussed earlier still applies, though, and surgeons weigh the benefit of better early pain control against the theoretical risk of impaired tissue repair when deciding how long to continue the NSAID postoperatively.

Who Should Be Cautious

Meloxicam is not appropriate for everyone with shoulder pain. People with a history of stomach ulcers, GI bleeding, or significant digestive problems should discuss alternatives or consider gastroprotective medication alongside meloxicam. Those with heart failure, uncontrolled high blood pressure, or chronic kidney disease face higher risks from any NSAID and may need a different approach entirely, such as acetaminophen, topical treatments, or corticosteroid injection.

Age is a compounding factor. Older adults are more likely to have the cardiovascular and kidney risk factors that make NSAIDs riskier, and they are also the demographic most likely to develop rotator cuff problems and shoulder arthritis. The fact that your shoulder hurts more as you age does not mean NSAIDs become safer to take. If you are over 65 or on blood thinners, anticoagulants, or blood pressure medications, the risk-benefit calculation changes and a shorter course at the lowest effective dose becomes more important.

People taking meloxicam for shoulder pain should also be aware that combining it with other NSAIDs, including over-the-counter ibuprofen or naproxen, does not provide additive benefit but does stack the side-effect risk. If you are already on a prescription meloxicam dose, adding ibuprofen from the medicine cabinet is not safe and not helpful. The same goes for aspirin interactions, though low-dose aspirin for cardiovascular protection is a nuance your prescriber should address directly.

When Meloxicam Is Not Enough

Some shoulder conditions simply do not respond well to oral anti-inflammatories alone. Frozen shoulder, or adhesive capsulitis, involves progressive stiffening of the joint capsule that often resists NSAIDs. Advanced glenohumeral osteoarthritis with bone-on-bone contact produces pain that has mechanical as much as inflammatory origins, and while meloxicam may take the edge off, it rarely provides adequate relief on its own. Large or full-thickness rotator cuff tears often require surgical repair, and the pain from structural damage cannot be fully addressed by reducing inflammation.

If you have been taking meloxicam for shoulder pain for more than two to three weeks and are not seeing meaningful improvement, that is a signal to revisit the diagnosis rather than increase the dose or extend the course. Persistent shoulder pain that does not respond to anti-inflammatories may indicate a structural problem that needs imaging, a different inflammatory condition, or pain that has become centrally sensitized and requires a different class of treatment altogether. Meloxicam is a good tool for the conditions it matches well, but no single medication is the answer to every shoulder problem.